Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions.
Moris P, Bauer KM, Currier JR, Friberg H, Eckels KH, Esquilin IO, Gibbons RV, Innis BL, Jarman RG, Simasathien S, Sun P, Thomas SJ, Watanaveeradej V. Moris P, et al. Among authors: watanaveeradej v. Hum Vaccin Immunother. 2019;15(9):2090-2105. doi: 10.1080/21645515.2019.1581536. Epub 2019 Apr 15. Hum Vaccin Immunother. 2019. PMID: 30829100 Free PMC article. Clinical Trial.
Dengue vaccine.
Simasathien S, Watanaveeradej V. Simasathien S, et al. Among authors: watanaveeradej v. J Med Assoc Thai. 2005 Nov;88 Suppl 3:S363-77. J Med Assoc Thai. 2005. PMID: 16858980 Review.
The study transplacental chikungunya virus antibody kinetics, Thailand.
Watanaveeradej V, Endy TP, Simasathien S, Kerdpanich A, Polprasert N, Aree C, Vaughn DW, Nisalak A. Watanaveeradej V, et al. Emerg Infect Dis. 2006 Nov;12(11):1770-2. doi: 10.3201/eid1211.051560. Emerg Infect Dis. 2006. PMID: 17283634 Free PMC article.
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.
Simasathien S, Thomas SJ, Watanaveeradej V, Nisalak A, Barberousse C, Innis BL, Sun W, Putnak JR, Eckels KH, Hutagalung Y, Gibbons RV, Zhang C, De La Barrera R, Jarman RG, Chawachalasai W, Mammen MP Jr. Simasathien S, et al. Among authors: watanaveeradej v. Am J Trop Med Hyg. 2008 Mar;78(3):426-33. Am J Trop Med Hyg. 2008. PMID: 18337339 Clinical Trial.
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants.
Watanaveeradej V, Simasathien S, Nisalak A, Endy TP, Jarman RG, Innis BL, Thomas SJ, Gibbons RV, Hengprasert S, Samakoses R, Kerdpanich A, Vaughn DW, Putnak JR, Eckels KH, Barrera Rde L, Mammen MP Jr. Watanaveeradej V, et al. Am J Trop Med Hyg. 2011 Aug;85(2):341-51. doi: 10.4269/ajtmh.2011.10-0501. Am J Trop Med Hyg. 2011. PMID: 21813857 Free PMC article. Clinical Trial.
Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial.
Feroldi E, Pancharoen C, Kosalaraksa P, Watanaveeradej V, Phirangkul K, Capeding MR, Boaz M, Gailhardou S, Bouckenooghe A. Feroldi E, et al. Among authors: watanaveeradej v. Hum Vaccin Immunother. 2012 Jul;8(7):929-37. doi: 10.4161/hv.20071. Epub 2012 Jul 1. Hum Vaccin Immunother. 2012. PMID: 22777096 Free article. Clinical Trial.
47 results